Park Ha Biological Technology is trading 10.3% down at $2.00, with no clear catalyst identified.

  • Available search results show no November 2 company announcement tied to the decline; they contain older company news instead.
  • The broader market is reported higher, but available results do not establish a company-specific, sector-wide, or global cause.